We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EAT:NYSEBrinker International, Inc. Analysis

Data as of 2026-09-24 - not real-time

$206.71

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At $206.71, Brinker International, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has lost 6.6% over the past 30 days. Relative strength is 43.8 — neutral — and the MACD signal is bearish. The recent range runs from support at $192.50 up to resistance at $249.77.
The shares look fair at 19.0 times earnings, though no sector average was available for comparison. Consensus targets land 27.7% above where the shares trade now. Revenue is growing at 5.1% on a 8.4% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 53.6%, a beta of 0.65 and a maximum drawdown of 26.2%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 4 out of 10.

Top Market Events

Brinker International, Inc. NYSE:EAT stock recently surged after issuing strong guidance that eclipsed mixed quarterly...Fintel reports that on September 22, 2026, Northcoast Research upgraded their outlook for Brinker International...Here is how Brinker International EAT and Target TGT have performed compared to their sector so far this year.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 167.82
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 167.82
  • Analyst targets imply +27.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Analyst targets imply +27.7% versus the current price
  • P/E ratio of 19.0
  • Return on equity of 119.6%

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin8.39%
P/E Ratio19.0
ROE119.57%
ROA14.28%
Debt/Equity395.76
P/B Ratio19.7
Op. Cash Flow$789.4M
Free Cash Flow$367.6M

Technical Analysis

TrendBullish
RSI43.8
Support$192.50
Resistance$249.77
MA 20$218.21
MA 50$217.46
MA 200$167.82
MACDBearish
VolumeIncreasing
Fear & Greed Index93.45

Valuation

Fair Value$92.86
Target Price$264.00
Upside/Downside27.72%
GradeFair
TypeGrowth

Risk Assessment

Beta0.65
Volatility53.60%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.